Cited 0 times in 
Cited 0 times in 
RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVAL
https://orcid.org/0000-0002-8342-8701
https://orcid.org/0000-0002-1645-7473
https://orcid.org/0000-0002-7347-1052
https://orcid.org/0000-0003-0189-3560
https://orcid.org/0000-0003-0297-3116
https://orcid.org/0000-0001-7948-1350Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.